These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

243 related articles for article (PubMed ID: 23951353)

  • 1. Evaluation of EGFR and RTK signaling in the electrotaxis of lung adenocarcinoma cells under direct-current electric field stimulation.
    Tsai HF; Huang CW; Chang HF; Chen JJ; Lee CH; Cheng JY
    PLoS One; 2013; 8(8):e73418. PubMed ID: 23951353
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Matuzumab and cetuximab activate the epidermal growth factor receptor but fail to trigger downstream signaling by Akt or Erk.
    Yoshida T; Okamoto I; Okabe T; Iwasa T; Satoh T; Nishio K; Fukuoka M; Nakagawa K
    Int J Cancer; 2008 Apr; 122(7):1530-8. PubMed ID: 18033688
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Signaling through the Phosphatidylinositol 3-Kinase (PI3K)/Mammalian Target of Rapamycin (mTOR) Axis Is Responsible for Aerobic Glycolysis mediated by Glucose Transporter in Epidermal Growth Factor Receptor (EGFR)-mutated Lung Adenocarcinoma.
    Makinoshima H; Takita M; Saruwatari K; Umemura S; Obata Y; Ishii G; Matsumoto S; Sugiyama E; Ochiai A; Abe R; Goto K; Esumi H; Tsuchihara K
    J Biol Chem; 2015 Jul; 290(28):17495-504. PubMed ID: 26023239
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lack of AKT activation in lung cancer cells with EGFR mutation is a novel marker of cetuximab sensitivity.
    Takata M; Chikumi H; Miyake N; Adachi K; Kanamori Y; Yamasaki A; Igishi T; Burioka N; Nanba E; Shimizu E
    Cancer Biol Ther; 2012 Apr; 13(6):369-78. PubMed ID: 22313637
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Gene expression of human lung cancer cell line CL1-5 in response to a direct current electric field.
    Huang CW; Chen HY; Yen MH; Chen JJ; Young TH; Cheng JY
    PLoS One; 2011; 6(10):e25928. PubMed ID: 21998723
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cell migration microfluidics for electrotaxis-based heterogeneity study of lung cancer cells.
    Li Y; Xu T; Zou H; Chen X; Sun D; Yang M
    Biosens Bioelectron; 2017 Mar; 89(Pt 2):837-845. PubMed ID: 27816579
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identifying novel targets of oncogenic EGF receptor signaling in lung cancer through global phosphoproteomics.
    Zhang X; Belkina N; Jacob HK; Maity T; Biswas R; Venugopalan A; Shaw PG; Kim MS; Chaerkady R; Pandey A; Guha U
    Proteomics; 2015 Jan; 15(2-3):340-55. PubMed ID: 25404012
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of direct current electric fields on lung cancer cell electrotaxis in a PMMA-based microfluidic device.
    Li Y; Xu T; Chen X; Lin S; Cho M; Sun D; Yang M
    Anal Bioanal Chem; 2017 Mar; 409(8):2163-2178. PubMed ID: 28078410
    [TBL] [Abstract][Full Text] [Related]  

  • 9. PGE2/EP3/SRC signaling induces EGFR nuclear translocation and growth through EGFR ligands release in lung adenocarcinoma cells.
    Bazzani L; Donnini S; Finetti F; Christofori G; Ziche M
    Oncotarget; 2017 May; 8(19):31270-31287. PubMed ID: 28415726
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of an EGFR-binding affibody molecule on intracellular signaling pathways.
    Nordberg E; Ekerljung L; Sahlberg SH; Carlsson J; Lennartsson J; Glimelius B
    Int J Oncol; 2010 Apr; 36(4):967-72. PubMed ID: 20198342
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hepatocyte growth factor induces resistance to anti-epidermal growth factor receptor antibody in lung cancer.
    Yamada T; Takeuchi S; Kita K; Bando H; Nakamura T; Matsumoto K; Yano S
    J Thorac Oncol; 2012 Feb; 7(2):272-80. PubMed ID: 22089117
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Reciprocal Negative Regulation between EGFR and DEPTOR Plays an Important Role in the Progression of Lung Adenocarcinoma.
    Zhou X; Guo J; Ji Y; Pan G; Liu T; Zhu H; Zhao J
    Mol Cancer Res; 2016 May; 14(5):448-57. PubMed ID: 26896556
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dacomitinib, an irreversible Pan-ErbB inhibitor significantly abrogates growth in head and neck cancer models that exhibit low response to cetuximab.
    Ather F; Hamidi H; Fejzo MS; Letrent S; Finn RS; Kabbinavar F; Head C; Wong SG
    PLoS One; 2013; 8(2):e56112. PubMed ID: 23405260
    [TBL] [Abstract][Full Text] [Related]  

  • 14. DC electric fields direct breast cancer cell migration, induce EGFR polarization, and increase the intracellular level of calcium ions.
    Wu D; Ma X; Lin F
    Cell Biochem Biophys; 2013; 67(3):1115-25. PubMed ID: 23657921
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sphingosine-1-phosphate receptor-3 signaling up-regulates epidermal growth factor receptor and enhances epidermal growth factor receptor-mediated carcinogenic activities in cultured lung adenocarcinoma cells.
    Hsu A; Zhang W; Lee JF; An J; Ekambaram P; Liu J; Honn KV; Klinge CM; Lee MJ
    Int J Oncol; 2012 May; 40(5):1619-26. PubMed ID: 22344462
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Activation of the AKT and STAT3 pathways and prolonged survival by a mutant EGFR in human lung cancer cells.
    Akca H; Tani M; Hishida T; Matsumoto S; Yokota J
    Lung Cancer; 2006 Oct; 54(1):25-33. PubMed ID: 16872715
    [TBL] [Abstract][Full Text] [Related]  

  • 17. AKT facilitates EGFR trafficking and degradation by phosphorylating and activating PIKfyve.
    Er EE; Mendoza MC; Mackey AM; Rameh LE; Blenis J
    Sci Signal; 2013 Jun; 6(279):ra45. PubMed ID: 23757022
    [TBL] [Abstract][Full Text] [Related]  

  • 18. HER2 amplification: a potential mechanism of acquired resistance to EGFR inhibition in EGFR-mutant lung cancers that lack the second-site EGFRT790M mutation.
    Takezawa K; Pirazzoli V; Arcila ME; Nebhan CA; Song X; de Stanchina E; Ohashi K; Janjigian YY; Spitzler PJ; Melnick MA; Riely GJ; Kris MG; Miller VA; Ladanyi M; Politi K; Pao W
    Cancer Discov; 2012 Oct; 2(10):922-33. PubMed ID: 22956644
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cetuximab response of lung cancer-derived EGF receptor mutants is associated with asymmetric dimerization.
    Cho J; Chen L; Sangji N; Okabe T; Yonesaka K; Francis JM; Flavin RJ; Johnson W; Kwon J; Yu S; Greulich H; Johnson BE; Eck MJ; Jänne PA; Wong KK; Meyerson M
    Cancer Res; 2013 Nov; 73(22):6770-9. PubMed ID: 24063894
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Electrotaxis Studies of Lung Cancer Cells using a Multichannel Dual-electric-field Microfluidic Chip.
    Hou HS; Chang HF; Cheng JY
    J Vis Exp; 2015 Dec; (106):e53340. PubMed ID: 26780080
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.